Other
Vasodilation
0
Pipeline Programs↗
3
Active Trials↗
0
Companies Involved↗
Vasodilation is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
15
clinical trials
Completed6 · 40%
Recruiting2 · 13%
Unknown status2 · 13%
Withdrawn2 · 13%
Terminated2 · 13%
Active, not recruiting1 · 7%
Clinical Trials
Trial Activity
15 trials
Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults
Completed·—·Phase 1·NCT03738943·9 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)